← The Wire
CATXNYSE
Perspective Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 728387
Develops radiopharmaceuticals using Lead-212 to deliver radiation specifically to cancer cells
$336M
Market cap
$3.55
Last close
+16.8%
1D
+16.4%
5D
1.7M
Volume
Price · last 39 sessions-10.8%
May 4L $2.93 · H $4.16Jun 29
486
Total filings
Jun 1, 2026
Last filing
12/31
Fiscal year end
8-KCompany UpdateJun 1, 20268-KShareholder VoteMay 27, 20268-KCompany UpdateMay 22, 202610-Q10-QMay 11, 20268-KResults of Operations · Company UpdateMay 11, 20268-KResults of Operations · Company UpdateMay 4, 20268-KCompany UpdateApr 20, 2026DEFA14ADEFA14AApr 16, 2026DEF 14ADEF 14AApr 16, 20268-KCompany UpdateApr 1, 202610-K10-KMar 16, 20268-KResults of Operations · Company UpdateMar 16, 20268-KMaterial Agreement · Company UpdateFeb 3, 2026424B5424B5Feb 3, 20268-KResults of Operations · Company UpdateFeb 2, 20268-KCompany UpdateJan 14, 20268-KCompany UpdateJan 12, 20268-KResults of Operations · Company UpdateJan 9, 20268-KCompany UpdateDec 1, 202510-Q10-QNov 10, 20258-KResults of Operations · Company UpdateNov 10, 20258-KCompany UpdateNov 6, 20258-KExecutive ChangeNov 3, 20258-KResults of Operations · Company UpdateOct 20, 20258-KCompany UpdateOct 1, 20258-KExecutive Change · Reg FD DisclosureSep 4, 20258-KExecutive Change · Reg FD DisclosureSep 3, 20258-KCompany UpdateSep 2, 202510-Q10-QAug 13, 20258-KResults of Operations · Company UpdateAug 13, 20258-KCompany UpdateAug 1, 20258-KCompany UpdateJul 3, 20258-KCompany UpdateJun 23, 20258-KCompany UpdateJun 3, 20258-KCompany UpdateMay 30, 20258-KShareholder VoteMay 28, 202510-Q10-QMay 12, 20258-KResults of Operations · Company UpdateMay 12, 20258-KCompany UpdateMay 1, 20258-KCompany UpdateApr 29, 2025DEFA14ADEFA14AApr 16, 2025DEF 14ADEF 14AApr 16, 20258-KCompany UpdateApr 11, 202510-K/A10-K/AMar 28, 202510-K10-KMar 26, 20258-KResults of Operations · Company UpdateMar 26, 20258-KCompany UpdateMar 17, 20258-KCompany UpdateMar 4, 20258-KCompany UpdateFeb 3, 20258-KCompany UpdateJan 24, 20258-KResults of Operations · Company UpdateJan 13, 20258-KExecutive Change · Reg FD DisclosureJan 6, 20258-KCompany UpdateDec 4, 20248-KCompany UpdateNov 21, 20248-KCompany UpdateNov 15, 2024SC 13GSC 13GNov 14, 2024SC 13GJANUS NEWNov 14, 202410-Q10-QNov 12, 20248-KResults of OperationsNov 12, 2024SC 13GSC 13GNov 8, 2024SC 13GSC 13GNov 7, 2024SC 13GSC 13GOct 24, 20248-KCompany UpdateOct 11, 20248-KMaterial Agreement · Acquisition / DispositionSep 20, 20248-KCompany UpdateSep 5, 20248-KExecutive ChangeAug 30, 20248-KExecutive ChangeAug 19, 20248-KMaterial Agreement · Company UpdateAug 13, 2024424B5424B5Aug 13, 202410-Q10-QAug 13, 20248-KCompany UpdateAug 13, 20248-K/AResults of OperationsAug 12, 20248-KResults of OperationsAug 12, 20248-KSecurity-Holder Rights · Bylaw AmendmentJun 14, 20248-KExecutive Change · Shareholder VoteMay 31, 20248-KMaterial Agreement · Company UpdateMay 29, 2024424B5424B5May 24, 20248-KCompany UpdateMay 20, 202410-Q10-QMay 15, 20248-KResults of OperationsMay 15, 2024
Insider Activity
◆ Cluster Buy · 2 insidersIn the 90 days to Nov 13, 2025: 2 insiders bought $42K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 13, 2025 | Hunt Jonathan RobertChief Accounting Officer | Buy | 11,000 | $2.03 | $22K |
| Nov 12, 2025 | Williamson Robert F IiiDirector | Buy | 9,498 | $2.10 | $20K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance